March 14th, 2023 Dr. Templeman was welcomed as a CTFO consultant and medical advisor. As Medical Director of Phytoceutical Research, Dr. Templeman is internationally sought after as a speaker and author on health, nutrition, and the healing properties of the Mangosteen fruit.
February 18th, 2023 XanthoMyst our brand new product is a proprietary Mangosteen Xanthone-Rich Product that is now shipping.
January 21st, 2023, The new CTFO Product XanthoMystTM is now available for pre-order and will start shipping the week of February 11th on a first order, first ship bases. Breakthrough Scientific Discovery of Myst’s Potency & Delivery.
November 5th, 2022, Our CBD Gummies have been upgraded in a very big way. Now our Gummies have both CBD and CBDa, come in 3 strengths, and come with our healthy 10xPure technology.
August 29th, 2022, The NEW CTFO 2.0 has LAUNCHED, and YOU can benefit.
June 25th, 2022, Patented & Exclusive 10XPURE Gold Sleep Product Launched
May 18th, 2022, CTFO’s Newest Sleep Solution (Est. Arrival 5/27) has 7 FAST-ACT ingredients that will gradually release over 7 hours to support longer quality Sleep.
January 22, 2022, CTFO launches 10XPURE Full Spectrum CBDA Line
November 2021 In preparation for CTFO’s massive future growth, the shipping warehouse in the United States moved from Florida to Chicago. This new warehouse can handle the volume that is coming and improve delivery times for many. Some recent orders that shipped to California arrived in 3 days, in a record time. However, due to Covid slowdowns, labor shortages, and holiday increased volume, please show patience.
In October 2021 CTFO launched a new product, Shape N Burn Plus that could revolutionize the weight loss market. It started to ship on October 12.
May 12, 2021 /PRNewswire/ — CTFO, Inc. (CTFO) set out to prove that its proprietary delivery oil 10xPURE™ could deliver bioavailable oily cannabinoids through your normally 60% aqueous body. CTFO announces a surprising and unexpected discovery: the ability to stabilize cannabinoid acid molecules such as CBDa, making the seemingly impossible, possible. This cannabinoid-acid stability milestone is supported by documented lab results with no significant potency degradation of the acids.
May 2021 CTFO is committed to enhancing our 10xPURE™ cannabinoid acid stabilization and a new era of product development with our partners based on over 18 months of promising personal anecdotes.
January 2021 CTFO launched another industry first, BLISS – extra-strength happy containing 200mgs of CBGa.
2020 Lab tested over 15 months of stability of 10xPure Super 1000 w/CBDA and the results were Perfect Stability.
In January 2019 CTFO commissioned an Exploratory Scientific Endeavor using CTFO 10xPURE™ delivery technology to demonstrate increased absorption and bioavailability of oily cannabinoids. CTFO unexpectedly discovered that this proprietary technology also stabilized the cannabinoid acids such as CBDa.
April 2019 CTFO published the Exploratory Scientific Endeavor on their website with data showing increased absorption, bioavailability, and protection of the cannabinoid acid molecules.
July 2019 CTFO launched the first of its kind product to the public, 10xPURE™ SUPER 1000 containing 300 mg of CBDa and 700 mg of cannabinoids.
“The launch of CTFO’s original 10xPURE™ Super 1000 brand, enriched with 300mgs CBDa, in July 2019 marked the beginning of a new era in harnessing the natural cannabinoid acid molecules for potential therapeutic benefit,” said Stuart Finger, Chief Executive Officer, CTFO.